Efficacy of the medical compound of teneligliptin 20 mg and canagliflozin 100 mg with Free Style Libre
Not Applicable
Recruiting
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000029015
- Lead Sponsor
- TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology
- Brief Summary
http://diabetes.diabetesjournals.org/content/67/Supplement_1/2304-PUB?utm_source=TrendMD&utm_medium=cpc&utm_campaign=Diabetes_TrendMD_0
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who have renal dysfunction (eGFR is less than 30ml/min/1.73m2) 2. Pregnant women 3. Patients judged by the doctor to be ineligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose transition (standard deviation and MAGE), and average blood glucose level by a Free Style Libre.
- Secondary Outcome Measures
Name Time Method Diabetes Treatment Satisfaction: DTSQ, glycoalbumin, urine albumin creatinine ratio, eGFR, glucagon, bodyweight.